|
January • February • March • April • May • June • July | |
| |
VOLUME 5, NUMBER 1 (January 2008) | |
 |
Community Oncology interviews the ASCO presidential candidates Carbohydrate restriction in patients with advanced cancer Management of metastatic colorectal cancer: the impact of recent clinical trials Adverse events alert: bevacizumab-associated diverticulitis Practice survival skills: caring in five minutes Community practice profile: Rocky Mountain Cancer Centers–Boulder Adenocarcinoma with choriocarcinoma in a patient with metastatic stomach cancer Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 2 (February 2008) | |
 |
Community Oncology interviews John E. Niederhuber, MD Eculizumab for paroxysmal nocturnal hemoglobinuria Image-guided radiation therapy: techniques and strategies Irinotecan pharmacogenetics: an overview for the community oncologist Patient-perceived breast cancer risk and psychological distress Ultrasonography-guided assessment of surgical margins in oral carcinoma A 72-year-old man with a large, left-upper-lobe lung mass Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 3 (March 2008) | |
 |
Community Oncology interviews David Eddy, MD, PhD Bendamustine in chronic lymphocytic leukemia Customizing EMR clickables PQRI: should you take part? Quality measurement in oncology practices Opinion leaders on quality in cancer: views from the field Quality and oncology: who’s on first? Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 4 (April 2008) | |
 |
Proceedings from the Third Annual Community Oncology Conference Lobbying members of Congress • Incorporating EMRs into your practice Calcium phosphate mouth rinse for preventing oral mucositis Talking to ODAC and meeting a stone wall Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 5 (May 2008) | |
 |
Community Oncology interviews Lawrence T. Goodnough, MD, on ESA restrictions Totect (dexrazoxane) for treatment of anthracycline extravasation Radiation therapy for cutaneous melanoma: 2008 update Practice–hospital partnerships: a marriage made for patients Safeguarding patients and avoiding medical errors in chemotherapy infusions suites Immune thrombocytopenic purpura in patients with nonhematologic cancers Implementation of sentinel node biopsy for breast cancer in a community hospital Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 6 (June 2008) | |
 |
Community Oncology interviews Ralph H. Hruban, MD, on fighting pancreatic cancer Denosumab: a new alternative for bone metastases Aromatase inhibitors vs tamoxifen as neoadjuvant therapy for breast cancer Extended-dosing epoetin alfa for chemotherapy-induced anemia Neurolymphomatosis: the challenge of diagnosis and treatment Hazardous drugs in oncology: impact of USP <797> and the NIOSH Alert Gadolinium–associated nephrogenic systemic fibrosis Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 7 (July 2008) | |
 |
The rationale for anti-CTLA-4 immunotherapy in melanoma Neoadjuvant chemotherapy prior to intraperitoneal chemotherapy in ovarian cancer Endoscopic ultrasonography in patients with pancreatic cancer Psychosocial considerations in hematopoietic stem cell transplantation A new method of assessing trends in breast cancer screening practices Hodgkin’s lymphoma during pregnancy Cutaneous toxicities of targeted cancer therapies Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 8 (August 2008) | |
 |
KRAS status as a predictor of response to EGFR inhibitors in Metastatic melanoma: an AJCC review Synchronous hilar cholangiocarcinoma and gallbladder cancer Adjuvant chemotherapy for resected non-small cell lung cancer Mantle cell lymphoma: an overview of diagnostic and therapeutic advances The FDA draws upon new authority to mandate elements of ESA labeling Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 9 (September 2008) | |
 |
Assesssing the risk of breast cancer recurrence in node-positive patients with Risk assessment and genetic counseling for multiple endocrine neoplasia type 1 (MEN1) Circulating tumor cells: ready for prime time Helping patients meet their financial obligations: skills needed and actions you should take Clopidogrel-associated TTP: the next chapter A physicians-only Web site: building an intellectual and activist community online Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 10 (October 2008) | |
 |
Cancer staging: achieving compliance with Commission on Cancer standards Recruiting patients to clinical trials Knocking down the barriers to recruiting members of minority groups Cardiotoxicity with fluorouracil and capecitabine revisited Integrating urologists into an oncology practice Temozolomide: applying healthcare fraud and abuse laws to oncology drugs Helping your patients find clinical trials through reliable Web sites Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 11 (November 2008) | |
 |
Gene-expression profiling and cancer of an unknown primary origin Red blood cell transfusion and chemotherapy administration Updates in the management of esophageal and gastric cancers Reverse isolation for neutropenic patients Stroke syndrome secondary to hypercoagulability of lung cancer Aromatase inhibitors and fracture risk in perimenopausal women The President’s Cancer Panel weighs in Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |
VOLUME 5, NUMBER 12 (December 2008) | |
 |
Metastatic breast cancer patients: addressing their unmet needs Romiplostim for treating thrombocytopenia in chronic ITP Cancer genetic testing: applying scientific discovery to clinical practice Improving patient outcomes with decitabine therapy for myelodysplastic syndromes Helping patients meet their financial obligations Prospects for community oncology in 2009 and beyond OncologySTAT: The year’s most important developments in cancer treatment Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
| |